Congenica is a UK company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and regional genetic testing laboratories

Congenica is a digital health company with the world’s leading clinical decision support platform for accelerated genomic data interpretation. Congenica software enables genomic medicine by integrating genetic data into healthcare, empowering clinicians to provide life-changing answers that transform the lives of individuals, patients and their families.

Genetic diseases are technically difficult to diagnose, and patients often spend years waiting for a diagnosis. Congenica convert genomic data into actionable information, expediting the process through more efficient and accurate analysis. This supports healthcare professionals in providing patients with robust diagnoses and precise, personalised care.

Born out of pioneering research from the Wellcome Sanger Institute and the NHS, Congenica is headquartered in Cambridge, UK, with a global footprint across the US and China. The Congenica platform is validated by the pivotal Genomics England 100,000 Genomes Project and we are the exclusive clinical interpretation partner to the NHS Genomic Medicine Service.

CIC point of contact: Michael Anstey

More from our Portfolio

Inivata

LIFE SCIENCES GROWTH
View company profile inivata.com

Morphogen-IX

LIFE SCIENCES GROWTH
View company profile www.morphogen-ix.com

Storm Therapeutics

LIFE SCIENCES GROWTH
View company profile stormtherapeutics.com/